# Risk: __Lack of drugs and vaccines__ (PBN__Risk_1349)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskISO_Impact

* [Governance, empowerment and engagement](../RiskISO/PBN__RiskISO_Purpose_6)

## Property: has_RiskSource

* [ebrahim_covid-19_2020](../Article/PBN__Article_112)

## Property: has_RiskName

Increased morbidity and mortality rates

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskTechnology

* [research and development of drugs and vaccines](../Technology/PBN__Technology_545)

## Property: has_RiskOwner

* [global health organizations](../Stakeholder/PBN__Stakeholder_860)
* [pharmaceutical companies](../Stakeholder/PBN__Stakeholder_124)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskDescription

No drugs or vaccines are available, overburdened health systems

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskMitigation

* [Rely on community interventions, transparency, and public engagement](../RiskMitigation/PBN__RiskMitigation_1843)

